Concanavalin A-conjugated gold nanoparticle/silica quantum dot (AuNPs/SiQDs-Con A)-based platform as a fluorescent nanoprobe for the bioimaging of glycan-positive cancer cells-Reference-Cited by-同舟云学术

Concanavalin A-conjugated gold nanoparticle/silica quantum dot (AuNPs/SiQDs-Con A)-based platform as a fluorescent nanoprobe for the bioimaging of glycan-positive cancer cells

Published:2022 Issue:14 Volume:12 Page:8492-8501
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Jafarzadeh Somayeh¹²,Bargahi Nasrin³,Shamloo Hassan Bagherpour⁴,Soleymani Jafar²^ORCID

Affiliation:

1. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2. Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

The glycan receptor is a glycosylphosphatidylinositol glycoprotein that is overexpressed on the surface of various cancer cells and has been utilized for wide applications.

Funder

Tabriz University of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA00035K

Reference40 articles.

1. WHO, accessed 31 October 2021, http://www.who.int/mediacentre/factsheets/fs297/en/

2. GLOBOCAN, accessed 28 August 2018, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx , http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

3. Prostate cancer: diagnostic criteria and role of immunohistochemistry